IISc-incubated Mynvax 
Dealstreet

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Advocates and court staff perform essential duties: Delhi HC says while exempting them from non-BS VI vehicle ban

Bombay High Court quashes Customs order flagged for citing non-existent AI-generated judgments

Outraging modesty provision under BNS applies to transgender women: Bombay High Court

NMC founder BR Shetty held liable for $5.4 billion healthcare fraud by Abu Dhabi court

ED is not super cop: Karnataka High Court quashes money laundering probe against Congress leader

SCROLL FOR NEXT